Table 3.
Day 1 | Day 2 | |||
---|---|---|---|---|
Baseline | Hyperoxia | Baseline | Vitamin C + Hyperoxia | |
Sm
(cm/s) |
8.50 ± 0.18 | 7.56 ± 0.26* | 8.31 ± 0.21 | t 8.51 ± 0.17† |
Em
(cm/s) |
12.87 ± 0.71 | 12.33 ± 0.65 | 13.15 ± 0.42 | 13.52 ± 0.66 |
Am
(cm/s) |
5.96 ± 0.41 | 6.53 ± 0.72 | 6.99 ± 0.33 | 7.08 ± 0.41 |
E (cm/s) | 81.38 ± 5.08 | 78.50 ± 4.57 | 80.38 ± 5.24 | 84.86 ± 5.92 |
A (cm/s) | 40.63 ± 3.63 | 39.50 ± 2.07 | 39.00 ± 2.44 | 39.43 ± 3.2 |
E/Em | 6.39 ± 0.36 | 6.43 ± 0.34 | 6.13 ± 0.37 | 6.38 ± 0.20 |
CBV
(cm/s) |
23.50 ± 2.31 | 17.00 ± 1.79* | 23.88 ± 1.36 | t 22.25 ± 1.45† |
CVR | 5.63 ± 0.88 | 7.32 ±0.94* | 4.83 ± 0.32 | t 5.29 ± 0.37† |
Values are mean ± S.E.M. Sm, peak systolic velocity in ejection period measured at mitral annulus; Em, early diastolic velocity at mitral annulus; Am, late diastolic velocity at mitral annulus; CBV, peak velocity of coronary blood velocity; CVR, coronary vascular resistance.
P< 0.05, vs. respective baseline.
P < 0.05, vs. day 1 hyperoxia